ALASTAIR THOMPSON to Phenotype
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Phenotype.
Connection Strength
0.116
-
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
Score: 0.042
-
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2009 Mar; 114(2):391.
Score: 0.036
-
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. J Pathol. 2014 Jul; 233(3):238-46.
Score: 0.014
-
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol. 2012 May 21; 301:122-40.
Score: 0.012
-
Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screen. Cell Cycle. 2008 Nov 01; 7(21):3417-27.
Score: 0.009
-
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170. J Pathol. 1998 Nov; 186(3):254-61.
Score: 0.005